Cargando…
Modulation of the Autophagy-Lysosomal Pathway in Hepatocellular Carcinoma Using Small Molecules
Hepatocellular carcinoma (HCC) accounts for approximately 90% of all cases of primary liver cancer; it is the third most frequent cause of cancer-related death worldwide. In early-stage disease, surgical resection and liver transplantation are considered curative treatments. However, the majority of...
Autores principales: | Lee, Yu Geon, Jeon, Tae–Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181071/ https://www.ncbi.nlm.nih.gov/pubmed/32235537 http://dx.doi.org/10.3390/molecules25071580 |
Ejemplares similares
-
The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors
por: Dong, Zhen, et al.
Publicado: (2018) -
Docosahexaenoic Acid, a Potential Treatment for Sarcopenia, Modulates the Ubiquitin–Proteasome and the Autophagy–Lysosome Systems
por: Lee, Jung Hoon, et al.
Publicado: (2020) -
Transcriptional regulation of autophagy‐lysosomal pathway in cancer
por: Chang, Xinzhong, et al.
Publicado: (2020) -
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches
por: Farzaneh, Zahra, et al.
Publicado: (2021) -
The role of autophagy-lysosomal pathway in motor neuron diseases
por: Tedesco, Barbara, et al.
Publicado: (2022)